O-6 EORTC 1707 VESTIGE: Adjuvant immunotherapy in patients (pts) with resected gastroesophageal adenocarcinoma (GEA) following preoperative chemotherapy with high risk for recurrence (ypN+ and/or R1)—an open-label randomized controlled phase II study

Elizabeth Smyth, M. Mauer, Chiara Alessandra Cella, Irit Ben‐Aharon, Guillaume Piessen, Lucjan Wyrwicz, Ghazwan Al-Haidari, Tania Fleitas, Valérie Boige, M. Stahl, Uwe M. Martens, Radka Obermannová, Carlos Gómez-Martín, Peter Thuss‐Patience, Virginia Arrazubi, Antonio Avallone, Kai‐Keen Shiu, Maike Collienne, A. Giraut, Florian Lordick